Skip to main content
Equibles
ZTS logo

ZTS · Zoetis Inc. · Webcasts, Transcripts & Audio

Track ZTS — free

Use ZTS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ZTS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$81.03 -0.97 (-1.18%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$33.48B
Shares
413.22M
Volume · Oct 23 2.86M Avg daily vol (3M) 5.13M

Zoetis Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Zoetis Inc. (ZTS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-05
Zoetis Inc. (ZTS) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-14
Zoetis Inc. (ZTS) September 14, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Zoetis Inc. (ZTS) Q2 2026 Earnings Call Transcript
Cautious tone Dermatology franchise dynamics U.S. companion animal pressure Pricing and gross-to-net actions
Revenue
$2.47B
▼ 0.2% YoY
Diluted EPS
$1.65
▲ 1.2% YoY
Gross margin
72.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
Zoetis Inc. (ZTS) June 2, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-28
Zoetis Inc. (ZTS) May 28, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-05-20
Zoetis Inc. (ZTS) May 20, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-05-20
Zoetis Inc. (ZTS) May 20, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Zoetis Inc. (ZTS) Q1 2026 Earnings Call Transcript
Cautious tone Competitive intensity Companion animal pressure OA Pain / Librela
Revenue
$2.26B
▲ 2.9% YoY
Diluted EPS
$1.42
▲ 6% YoY
Gross margin
71.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-10
Zoetis Inc. (ZTS) March 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-12
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Positive tone Livestock and international growth Simparica / Trio franchise 2026 financial guidance
Revenue
$2.40B*
▲ 3.4% YoY
Gross margin
70.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-12-02
Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript
Positive tone OA pain franchise (Librela/Solensia/Lenivia/Portela) Innovation pipeline and approvals Parasiticides franchise (Simparica/Trio)
Revenue
$2.40B
▲ 0.5% YoY
Diluted EPS
$1.63
▲ 8.7% YoY
Gross margin
71.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript
Confident tone International and geographic growth Companion Animal franchise momentum Librela / OA Pain adoption challenges
Revenue
$2.47B
▲ 4.8% YoY
Diluted EPS
$1.63
▲ 19% YoY
Gross margin
73.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Zoetis Inc. (ZTS) Q1 2025 Earnings Call Transcript
Confident tone Companion animal growth (Simparica, dermatology, OA pain) Librela / OA pain adoption ramp Tariffs and pharmaceutical policy (Section 232)
Revenue
$2.20B
▲ 0.4% YoY
Diluted EPS
$1.34
▲ 2.3% YoY
Gross margin
71.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript
Confident tone Companion animal growth and key franchises Osteoarthritis pain franchise (Librela/Solensia) 2025 financial guidance and outlook
Revenue
$2.32B*
▲ 4.7% YoY
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript
Confident tone Librela/Solensia (OA pain franchise) Dermatology franchise (Apoquel/Cytopoint) Simparica Trio (parasiticides)
Revenue
$2.39B
▲ 11% YoY
Diluted EPS
$1.50
▲ 16.3% YoY
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Zoetis Inc. (ZTS) Q2 2024 Earnings Call Transcript
Confident tone Dermatology franchise (Apoquel/Cytopoint) Companion animal innovation (Librela/Solensia) Livestock portfolio
Revenue
$2.36B
▲ 8.3% YoY
Diluted EPS
$1.37
▼ 5.5% YoY
Gross margin
71.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Zoetis Inc. (ZTS) Q1 2024 Earnings Call Transcript
Confident tone Companion animal / OA pain franchise (Librela, Solensia) Librela safety / FDA and vet engagement Parasiticides (Simparica, Simparica Trio)
Revenue
$2.19B
▲ 9.5% YoY
Diluted EPS
$1.31
▲ 10.1% YoY
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-13
Zoetis Inc. (ZTS) Q4 2023 Earnings Call Transcript
Confident tone Librela / Solensia (OA pain monoclonal antibodies) 2024 financial guidance and outlook Companion animal portfolio
Revenue
$2.21B*
▲ 8.5% YoY
Gross margin
67.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Zoetis Inc. (ZTS) Q3 2023 Earnings Call Transcript
Revenue
$2.15B
▲ 7.4% YoY
Diluted EPS
$1.29
▲ 14.2% YoY
Gross margin
70.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Zoetis Inc. (ZTS) Q2 2023 Earnings Call Transcript
Revenue
$2.18B
▲ 6.2% YoY
Diluted EPS
$1.45
▲ 29.5% YoY
Gross margin
72.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Zoetis Inc. (ZTS) Q1 2023 Earnings Call Transcript
Revenue
$2.00B
▲ 0.7% YoY
Diluted EPS
$1.19
▼ 5.6% YoY
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-14
Zoetis Inc. (ZTS) Q4 2022 Earnings Call Transcript
Revenue
$2.04B*
▲ 3.7% YoY
Gross margin
68.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Zoetis Inc. (ZTS) Q3 2022 Earnings Call Transcript
Revenue
$2.00B
▲ 0.6% YoY
Diluted EPS
$1.13
▼ 2.6% YoY
Gross margin
69.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Zoetis Inc. (ZTS) Q2 2022 Earnings Call Transcript
Revenue
$2.05B
▲ 5.3% YoY
Diluted EPS
$1.12
▲ 4.7% YoY
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Zoetis Inc. (ZTS) Q1 2022 Earnings Call Transcript
Revenue
$1.99B
▲ 6.1% YoY
Diluted EPS
$1.26
▲ 7.7% YoY
Gross margin
71.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
Zoetis Inc. (ZTS) Q4 2021 Earnings Call Transcript
Revenue
$1.97B*
▲ 8.9% YoY
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Zoetis Inc. (ZTS) Q3 2021 Earnings Call Transcript
Revenue
$1.99B
▲ 11.4% YoY
Diluted EPS
$1.16
▲ 16% YoY
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Zoetis Inc. (ZTS) Q2 2021 Earnings Call Transcript
Revenue
$1.95B
▲ 25.8% YoY
Diluted EPS
$1.07
▲ 35.4% YoY
Gross margin
70.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Zoetis Inc. (ZTS) Q1 2021 Earnings Call Transcript
Revenue
$1.87B
▲ 22% YoY
Diluted EPS
$1.17
▲ 33% YoY
Gross margin
70.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-16
Zoetis Inc. (ZTS) Q4 2020 Earnings Call Transcript
Revenue
$1.81B*
▲ 7.9% YoY
Gross margin
66.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Zoetis Inc. (ZTS) Q3 2020 Earnings Call Transcript
Revenue
$1.79B
▲ 12.8% YoY
Diluted EPS
$1.00
▲ 11.1% YoY
Gross margin
69.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript
Revenue
$1.55B
▲ 0.1% YoY
Diluted EPS
$0.79
▲ 2.6% YoY
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Zoetis Inc. (ZTS) Q1 2020 Earnings Call Transcript
Revenue
$1.53B
▲ 5.4% YoY
Diluted EPS
$0.88
▲ 35.4% YoY
Gross margin
70.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Zoetis Inc. (ZTS) Q4 2019 Earnings Call
Revenue
$1.67B
▲ 7% YoY
Diluted EPS
$0.80
▲ 12.7% YoY
Gross margin
68.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–34 of 34 webcasts
Key facts CIK 1555280 CUSIP 98978V103 13F (30d) 349 filings 329 filers Visit website Investor relations